ArticleScientific reports2025

Early CMV DNAemia during letermovir prophylaxis predicts lower risk of late CMV infection and is associated with enhanced T-cell immunity after alloHSCT.

Timothé Duplessix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.